AI Article Synopsis

  • The study analyzed 18 cases of laryngeal carcinoma using comparative genomic hybridization to uncover genetic variances related to tumor development.
  • Each case exhibited an average of 12.9 abnormal regions, with more losses (7.2) than gains (5.7) in chromosomal material.
  • Key findings include significant chromosomal gains in 3q, 5p, and 11q, and losses in regions such as 3p and 5q, indicating the involvement of oncogenes and tumor suppressor genes in the cancer's progression.

Article Abstract

In order to find out the genes involved in the tumorigenesis of laryngeal carcinoma, we analyzed 18 laryngeal carcinoma with comparative genomic hybridization. Results show that each one has different degree of variances, included gains and losses of partial and whole chromosome. Each case has 12.9 abnormal regions averagely; losses are more than gains, equal to 7.2 and 5.7 per case respectively. Main regions are gains in chromosomes 3q (78%), 5p (61%), 11q (56%), 1q (50%), 8p (44%), 8q (39%) and 15q (39%), and losses of 3p (70%), 5q (78%), 9p (67%), 13q (50%), 1p (44%) and 14q (39%). There are many specific gains and losses in several chromosomes,especially the increase of copy number karyotype in 1p13-21(8/18), 3p21-23 (14/18), 5p21-22 (14/18), 9p12-pter (10/18) and 13q21-31 (8/18), while the decrease in 1q11-21 (11/18), 3q15-21 (12/18), 8p22-24 (6/18), 11q12-13 (8/18), 15q21-23 (7/18), 18p11 (8/18) are the characteristic varieties. These results suggest that there are oncogene, tumor suppressor gene and other associated genes involved in the tumorigenesis.

Download full-text PDF

Source

Publication Analysis

Top Keywords

genomic hybridization
8
genes involved
8
involved tumorigenesis
8
laryngeal carcinoma
8
gains losses
8
50% 44%
8
[comparative genomic
4
hybridization analysis
4
analysis laryngeal
4
laryngeal carcinoma]
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!